NVAX (STOCKS)
Novavax Inc
$8.130100
+0.010100 (+0.12%)
Prev close: $8.120000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- John C.s Jacobs
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,319.78M
- Employees
- 1,992
- P/E (TTM)
- 3.19
- P/B (TTM)
- -10.33
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
2
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.11 | $-0.50 | +0.6067 | +122.15% |
|
Sep 2025 (Q3)
|
$-1.25 | $-1.21 | -0.0400 | -3.31% |
|
Jun 2025 (Q2)
|
$0.62 | $-0.09 | +0.7052 | +827.70% |
|
Mar 2025 (Q1)
|
$2.93 | $0.72 | +2.2099 | +306.89% |
Financial Statements
| Revenues | $1.12B |
| Benefits Costs and Expenses | $681.31M |
| Cost Of Revenue | $73.04M |
| Costs And Expenses | $670.68M |
| Gross Profit | $1.05B |
| Operating Expenses | $597.64M |
| Selling, General, and Administrative Expenses | $157.48M |
| Depreciation and Amortization | $27.61M |
| Research and Development | $342.32M |
| Other Operating Expenses | $70.23M |
| Operating Income/Loss | $452.80M |
| Income/Loss From Continuing Operations After Tax | $440.30M |
| Income/Loss From Continuing Operations Before Tax | $442.17M |
| Income Tax Expense/Benefit | $1.87M |
| Income Tax Expense/Benefit, Current | $1.88M |
| Net Income/Loss | $440.30M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $440.30M |
| Net Income/Loss Available To Common Stockholders, Basic | $440.30M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.72 |
| Diluted Earnings Per Share | $2.58 |
| Basic Average Shares | 161,991,000 |
| Diluted Average Shares | 173,103,000 |
| Assets | $1.18B |
| Current Assets | $978.28M |
| Inventory | $11.55M |
| Other Current Assets | $966.73M |
| Noncurrent Assets | $198.24M |
| Fixed Assets | $44.80M |
| Other Non-current Assets | $153.44M |
| Liabilities | $1.30B |
| Current Liabilities | $459.95M |
| Accounts Payable | $24.58M |
| Wages | $50.98M |
| Other Current Liabilities | $384.40M |
| Noncurrent Liabilities | $844.32M |
| Equity | -$127.75M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$127.75M |
| Liabilities And Equity | $1.18B |
| Net Cash Flow From Operating Activities | -$244.64M |
| Net Cash Flow From Operating Activities, Continuing | -$244.64M |
| Net Cash Flow From Investing Activities | -$78.27M |
| Net Cash Flow From Investing Activities, Continuing | -$78.27M |
| Net Cash Flow From Financing Activities | $27.74M |
| Net Cash Flow From Financing Activities, Continuing | $27.74M |
| Exchange Gains/Losses | $5.93M |
| Net Cash Flow | -$289.24M |
| Net Cash Flow, Continuing | -$295.17M |
| Comprehensive Income/Loss | $464.87M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $464.87M |
| Other Comprehensive Income/Loss | $464.87M |
| Other Comprehensive Income/Loss Attributable To Parent | $24.57M |